Jumpcan Pharmaceutical Co., Ltd.
As of 18 November 2026, for the company name Jumpcan Pharmaceutical Co., Ltd. as recorded, the chemical-drug catalogue lists 34 active records with this name as holder; 18 active API registrations list this name as first registered company.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.
Drug filings
65 acceptance records as first applicant, grouped into 41 source drug names. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
柴葛退热口服液 · No verified English name 1 records · Latest accepted 2026/04/28
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXZS2600023 | New drug | 2026/04/28 | Jumpcan Pharmaceutical Co., Ltd. | CDE ↗ |
小儿便通颗粒 · No verified English name 1 records · Latest accepted 2025/07/01
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXZS2500026 | New drug | 2025/07/01 | Jumpcan Pharmaceutical Co., Ltd. | CDE ↗ |
小儿腹泻宁(泡腾颗粒) · No verified English name 1 records · Latest accepted 2025/05/30
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2501060 | Supplement | 2025/05/30 | Jumpcan Pharmaceutical Co., Ltd. | CDE ↗ |
朴实颗粒 · No verified English name 2 records · Latest accepted 2025/04/25
Supplement · 2
Mesalazine Sustained-release Granules 1 records · Latest accepted 2025/01/09
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500150 | Generic | 2025/01/09 | Jumpcan Pharmaceutical Co., Ltd. | CDE ↗ |
赖氨肌醇维B12口服溶液 · No verified English name 2 records · Latest accepted 2024/11/01
Supplement · 2
维生素B6注射液 · No verified English name 1 records · Latest accepted 2024/07/08
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402061 | Generic | 2024/07/08 | Jumpcan Pharmaceutical Co., Ltd. | CDE ↗ |
普仑司特干糖浆 · No verified English name 1 records · Latest accepted 2024/03/15
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400849 | Generic | 2024/03/15 | Jumpcan Pharmaceutical Co., Ltd. | CDE ↗ |
Iron Proteinsuccinylate Oral Solution 1 records · Latest accepted 2024/02/02
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2400187 | Supplement | 2024/02/02 | Jumpcan Pharmaceutical Co., Ltd. | CDE ↗ |
金花止咳颗粒 · No verified English name 2 records · Latest accepted 2023/08/01
Supplement · 2
Sodium Valproate Concentrated Solution for Injection 3 records · Latest accepted 2023/07/06
Supplement · 1Generic · 2
Roxadustat Capsules 2 records · Latest accepted 2023/07/03
Generic · 2
Potassium Chloride Granules 2 records · Latest accepted 2023/06/10
Generic · 2
Pediatric Faropenem Sodium Granules 2 records · Latest accepted 2023/05/31
Generic · 2
Famotidine Injection 1 records · Latest accepted 2023/05/31
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2301461 | Generic | 2023/05/31 | Jumpcan Pharmaceutical Co., Ltd.; Tai Ji Group Sichuan Tai Ji Pharmaceutical Co., Ltd. romanized | CDE ↗ |
聚乙二醇钠钾散 · No verified English name 2 records · Latest accepted 2023/04/04
Generic · 2
Sodium Valproate Sustained-release Tablets(I) 1 records · Latest accepted 2023/02/18
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300573 | Generic | 2023/02/18 | Jumpcan Pharmaceutical Co., Ltd. | CDE ↗ |
Methylthionine Chloride Injection 3 records · Latest accepted 2023/02/18
Supplement · 3
西他沙星细粒 · No verified English name 1 records · Latest accepted 2023/02/14
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300503 | Generic | 2023/02/14 | Jumpcan Pharmaceutical Co., Ltd. | CDE ↗ |
Levofloxacin and Sodium Chloride Injection 2 records · Latest accepted 2023/01/31
Generic · 2
小儿豉翘清热糖浆 · No verified English name 1 records · Latest accepted 2023/01/28
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXZS2300003 | New drug | 2023/01/28 | Jumpcan Pharmaceutical Co., Ltd. | CDE ↗ |
Lafutidine Tablets 2 records · Latest accepted 2023/01/17
Generic · 2
Alanyl Glutamine Injection 2 records · Latest accepted 2023/01/13
Supplement · 2
碳酸利多卡因注射液 · No verified English name 2 records · Latest accepted 2023/01/11
Supplement · 2
Pregabalin Oral Solution 2 records · Latest accepted 2022/12/28
Supplement · 1Generic · 1
盐酸非索非那定干混悬剂 · No verified English name 2 records · Latest accepted 2022/11/11
Generic · 2
Lidocaine Hydrochloride Injection 2 records · Latest accepted 2022/10/18
Supplement · 2
川芎清脑颗粒 · No verified English name 2 records · Latest accepted 2022/09/01
Supplement · 2
Esmolol Hydrochloride Injection 1 records · Latest accepted 2022/07/27
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201147 | Generic | 2022/07/27 | Jumpcan Pharmaceutical Co., Ltd. | CDE ↗ |
Ibuprofen Suspension 1 records · Latest accepted 2022/04/28
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200688 | Generic | 2022/04/28 | Jumpcan Pharmaceutical Co., Ltd. | CDE ↗ |
盐酸利多卡因胶浆 · No verified English name 1 records · Latest accepted 2022/04/27
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2200698 | Supplement | 2022/04/27 | Jumpcan Pharmaceutical Co., Ltd. | CDE ↗ |
Nimodipine Injection 2 records · Latest accepted 2022/04/24
Supplement · 2
Azithromycin for Suspension 1 records · Latest accepted 2022/01/24
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200166 | Generic | 2022/01/24 | Jumpcan Pharmaceutical Co., Ltd. | CDE ↗ |
Ropivacaine hydrochloride injection 2 records · Latest accepted 2021/10/21
Supplement · 2
三拗片 · No verified English name 1 records · Latest accepted 2021/09/13
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2101644 | Supplement | 2021/09/13 | Jumpcan Pharmaceutical Co., Ltd. | CDE ↗ |
健胃消食口服液 · No verified English name 1 records · Latest accepted 2021/09/13
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2101645 | Supplement | 2021/09/13 | Jumpcan Pharmaceutical Co., Ltd. | CDE ↗ |
Atomoxetine Hydrochloride Oral Solution 1 records · Latest accepted 2021/09/02
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101661 | Generic | 2021/09/02 | Jumpcan Pharmaceutical Co., Ltd. | CDE ↗ |
Rabeprazole Sodium Enteric-coated Tablets 1 records · Latest accepted 2021/08/23
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101620 | Generic | 2021/08/23 | Jumpcan Pharmaceutical Co., Ltd. | CDE ↗ |
小儿豉翘清热颗粒 · No verified English name 4 records · Latest accepted 2021/05/27
Supplement · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2101150 | Supplement | 2021/05/27 | Jumpcan Pharmaceutical Co., Ltd. | CDE ↗ |
| CYZB2101149 | Supplement | 2021/05/27 | Jumpcan Pharmaceutical Co., Ltd. | CDE ↗ |
| CYZB2100148 | Supplement | 2021/01/27 | Jumpcan Pharmaceutical Co., Ltd. | CDE ↗ |
| CYZB2100147 | Supplement | 2021/01/27 | Jumpcan Pharmaceutical Co., Ltd. | CDE ↗ |
蒲地蓝消炎口服液 · No verified English name 1 records · Latest accepted 2021/01/20
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2100083 | Supplement | 2021/01/20 | Jumpcan Pharmaceutical Co., Ltd. | CDE ↗ |
Olprinone Hydrochloride Injection 1 records · Latest accepted 2021/01/19
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2100070 | Generic | 2021/01/19 | Jumpcan Pharmaceutical Co., Ltd. | CDE ↗ |
Changes in the last 90 days
0 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
- No matching records were found in the currently loaded source data; coverage dates are listed below.
Under review
2 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Catalogue holder records
34 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Mesalazine Sustained-release Granules | Jumpcan Pharmaceutical Co., Ltd. | Jumpcan Pharmaceutical Co., Ltd. | 国药准字H20265499 | 2026/08/04 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 复方聚乙二醇(3350)电解质散 · No verified English name | Jumpcan Pharmaceutical Co., Ltd. | Jumpcan Pharmaceutical Co., Ltd. | 国药准字H20254659 | 2025/06/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 复方聚乙二醇(3350)电解质散 · No verified English name | Jumpcan Pharmaceutical Co., Ltd. | Jumpcan Pharmaceutical Co., Ltd. | 国药准字H20254660 | 2025/06/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Potassium Chloride Granules | Jumpcan Pharmaceutical Co., Ltd. | Jumpcan Pharmaceutical Co., Ltd. | 国药准字H20253821 | 2025/04/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Potassium Chloride Granules | Jumpcan Pharmaceutical Co., Ltd. | Jumpcan Pharmaceutical Co., Ltd. | 国药准字H20253820 | 2025/04/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 西他沙星颗粒 · No verified English name | Jumpcan Pharmaceutical Co., Ltd. | Jumpcan Pharmaceutical Co., Ltd. | 国药准字H20253317 | 2025/01/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Roxadustat Capsules | Jumpcan Pharmaceutical Co., Ltd. | Jumpcan Pharmaceutical Co., Ltd. | 国药准字H20253058 | 2025/01/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Roxadustat Capsules | Jumpcan Pharmaceutical Co., Ltd. | Jumpcan Pharmaceutical Co., Ltd. | 国药准字H20253059 | 2025/01/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Pediatric Faropenem Sodium Granules | Jumpcan Pharmaceutical Co., Ltd. | Jumpcan Pharmaceutical Co., Ltd. | 国药准字H20249686 | 2024/12/06 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Famotidine Injection | Jumpcan Pharmaceutical Co., Ltd. | Tai Ji Group Sichuan Tai Ji Pharmaceutical Co., Ltd. romanized | 国药准字H20249246 | 2024/11/05 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lafutidine Tablets | Jumpcan Pharmaceutical Co., Ltd. | Jumpcan Pharmaceutical Co., Ltd. | 国药准字H20244766 | 2024/08/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Alanyl Glutamine Injection | Jumpcan Pharmaceutical Co., Ltd. | Jumpcan Pharmaceutical Co., Ltd. | 国药准字H20066620 | 2024/06/21 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Alanyl Glutamine Injection | Jumpcan Pharmaceutical Co., Ltd. | Jumpcan Pharmaceutical Co., Ltd. | 国药准字H20067054 | 2024/06/21 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Levofloxacin and Sodium Chloride Injection | Jumpcan Pharmaceutical Co., Ltd. | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | 国药准字H20244087 | 2024/06/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Levofloxacin and Sodium Chloride Injection | Jumpcan Pharmaceutical Co., Ltd. | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | 国药准字H20244086 | 2024/06/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 盐酸非索非那定干混悬剂 · No verified English name | Jumpcan Pharmaceutical Co., Ltd. | Jumpcan Pharmaceutical Co., Ltd. | 国药准字H20243968 | 2024/06/11 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 盐酸非索非那定干混悬剂 · No verified English name | Jumpcan Pharmaceutical Co., Ltd. | Jumpcan Pharmaceutical Co., Ltd. | 国药准字H20243967 | 2024/06/11 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sodium Valproate Concentrated Solution for Injection | Jumpcan Pharmaceutical Co., Ltd. | Jumpcan Pharmaceutical Co., Ltd. | 国药准字H20247119 | 2024/05/31 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Nimodipine Injection | Jumpcan Pharmaceutical Co., Ltd. | Jumpcan Pharmaceutical Co., Ltd. | 国药准字H20000682 | 2024/01/04 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Nimodipine Injection | Jumpcan Pharmaceutical Co., Ltd. | Jumpcan Pharmaceutical Co., Ltd. | 国药准字H20030306 | 2024/01/04 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Lidocaine Hydrochloride Injection | Jumpcan Pharmaceutical Co., Ltd. | Jumpcan Pharmaceutical Co., Ltd. | 国药准字H32025323 | 2023/12/04 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Lidocaine Hydrochloride Injection | Jumpcan Pharmaceutical Co., Ltd. | Jumpcan Pharmaceutical Co., Ltd. | 国药准字H32024798 | 2023/12/04 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Esmolol Hydrochloride Injection | Jumpcan Pharmaceutical Co., Ltd. | Jumpcan Pharmaceutical Co., Ltd. | 国药准字H20234407 | 2023/10/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Azithromycin for Suspension | Jumpcan Pharmaceutical Co., Ltd. | Jumpcan Pharmaceutical Co., Ltd. | 国药准字H20233759 | 2023/06/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sodium Valproate Concentrated Solution for Injection | Jumpcan Pharmaceutical Co., Ltd. | Jumpcan Pharmaceutical Co., Ltd. | 国药准字H20233117 | 2023/01/31 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sodium Valproate Concentrated Solution for Injection | Jumpcan Pharmaceutical Co., Ltd. | Jumpcan Pharmaceutical Co., Ltd. | 国药准字H20233116 | 2023/01/31 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Rabeprazole Sodium Enteric-coated Tablets | Jumpcan Pharmaceutical Co., Ltd. | Jumpcan Pharmaceutical Co., Ltd. | 国药准字H20223845 | 2022/11/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ropivacaine hydrochloride injection | Jumpcan Pharmaceutical Co., Ltd. | Jumpcan Pharmaceutical Co., Ltd. | 国药准字H20203095 | 2022/10/25 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ropivacaine hydrochloride injection | Jumpcan Pharmaceutical Co., Ltd. | Jumpcan Pharmaceutical Co., Ltd. | 国药准字H20203094 | 2022/10/25 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Olprinone Hydrochloride Injection | Jumpcan Pharmaceutical Co., Ltd. | Jumpcan Pharmaceutical Co., Ltd. | 国药准字H20223247 | 2022/04/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Magnesium Sulfate, Sodium Sulfate and Potassium Sulfate Concentrate Oral Solution | Jumpcan Pharmaceutical Co., Ltd. | Jumpcan Pharmaceutical Co., Ltd. | 国药准字H20223027 | 2022/01/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Prucalopride Succinate Tablets | Jumpcan Pharmaceutical Co., Ltd. | Jumpcan Pharmaceutical Co., Ltd. | 国药准字H20203603 | 2020/11/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Prucalopride Succinate Tablets | Jumpcan Pharmaceutical Co., Ltd. | Jumpcan Pharmaceutical Co., Ltd. | 国药准字H20203604 | 2020/11/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sodium Valproate Sustained-release Tablets(I) | Jumpcan Pharmaceutical Co., Ltd. | Jumpcan Pharmaceutical Co., Ltd. | 国药准字H20266208 | 2026/10/13 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
18 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| 本维莫德 · No verified English name | Jumpcan Pharmaceutical Co., Ltd. | Y20240000506 | A | 2026/01/05 | CDE ↗ |
| 雷贝拉唑钠 · No verified English name | Jumpcan Pharmaceutical Co., Ltd. | Y20230000700 | A | 2026/05/20 | CDE ↗ |
| 盐酸罗哌卡因 · No verified English name | Jumpcan Pharmaceutical Co., Ltd. | Y20230000699 | A | 2025/07/31 | CDE ↗ |
| 布立西坦 · No verified English name | Jumpcan Pharmaceutical Co., Ltd. | Y20230000249 | I | 2023/04/06 | CDE ↗ |
| 罗沙司他 · No verified English name | Jumpcan Pharmaceutical Co., Ltd. | Y20220001295 | A | 2025/09/11 | CDE ↗ |
| 西他沙星 · No verified English name | Jumpcan Pharmaceutical Co., Ltd. | Y20220001101 | A | 2025/02/09 | CDE ↗ |
| 硫酸钠 · No verified English name | Jumpcan Pharmaceutical Co., Ltd. | Y20200000423 | A | 2026/08/30 | CDE ↗ |
| 硫酸钾 · No verified English name | Jumpcan Pharmaceutical Co., Ltd. | Y20200000424 | A | 2026/08/30 | CDE ↗ |
| 蛋白琥珀酸铁 · No verified English name | Jumpcan Pharmaceutical Co., Ltd. | Y20190009894 | A | 2025/09/30 | CDE ↗ |
| 普卢利沙星 · No verified English name | Jumpcan Pharmaceutical Co., Ltd. | Y20190007358 | A | — | CDE ↗ |
| 亚甲蓝 · No verified English name | Jumpcan Pharmaceutical Co., Ltd. | Y20190006930 | A | 2025/11/19 | CDE ↗ |
| 吗替麦考酚酯 · No verified English name | Jumpcan Pharmaceutical Co., Ltd. | Y20190006082 | A | — | CDE ↗ |
| 盐酸利多卡因 · No verified English name | Jumpcan Pharmaceutical Co., Ltd. | Y20190004675 | A | 2026/02/26 | CDE ↗ |
| 利多卡因 · No verified English name | Jumpcan Pharmaceutical Co., Ltd. | Y20190004418 | A | 2025/06/26 | CDE ↗ |
| 丙胺卡因 · No verified English name | Jumpcan Pharmaceutical Co., Ltd. | Y20190004417 | A | 2025/07/12 | CDE ↗ |
| 盐酸利托君 · No verified English name | Jumpcan Pharmaceutical Co., Ltd. | Y20190001333 | A | — | CDE ↗ |
| 蛋白琥珀酸铁 · No verified English name | Jumpcan Pharmaceutical Co., Ltd. | Y20170001925 | I | — | CDE ↗ |
| 埃索美拉唑钠 · No verified English name | Jumpcan Pharmaceutical Co., Ltd. | Y20170000563 | A | 2022/09/30 | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
12 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Potassium Chloride Granules | CYHB2600138 | Supplement | 2026/01/22 | Chongqing An Nuo Sheng Sheng Ming Technology Co., Ltd. romanized; Jumpcan Pharmaceutical Co., Ltd. | CDE ↗ |
| Potassium Chloride Granules | CYHB2600137 | Supplement | 2026/01/22 | Chongqing An Nuo Sheng Sheng Ming Technology Co., Ltd. romanized; Jumpcan Pharmaceutical Co., Ltd. | CDE ↗ |
| Esmolol Hydrochloride Injection | CYHB2502121 | Supplement | 2025/10/18 | Chongqing An Nuo Sheng Sheng Ming Technology Co., Ltd. romanized; Jumpcan Pharmaceutical Co., Ltd. | CDE ↗ |
| 鼾眠颗粒 · No verified English name | CXZL2500077 | New drug | 2025/09/16 | Shandong Kang Zhong Hong Pharmaceuticals Technology Kai Fa Co., Ltd. romanized; Jumpcan Pharmaceutical Co., Ltd. | CDE ↗ |
| Potassium Chloride Granules | CYHB2500011 | Supplement | 2025/01/03 | Chongqing Yao Gu Pharmaceutical Co., Ltd. romanized; Jumpcan Pharmaceutical Co., Ltd. | CDE ↗ |
| Potassium Chloride Granules | CYHB2500010 | Supplement | 2025/01/03 | Chongqing Yao Gu Pharmaceutical Co., Ltd. romanized; Jumpcan Pharmaceutical Co., Ltd. | CDE ↗ |
| 复方聚乙二醇电解质散(儿童型) · No verified English name | CYHS2403697 | Generic | 2024/10/31 | Chongqing Yao Gu Pharmaceutical Co., Ltd. romanized; Jumpcan Pharmaceutical Co., Ltd. | CDE ↗ |
| Iron Proteinsuccinylate Oral Solution | CYHS2402369 | Generic | 2024/07/26 | Chongqing Yao Gu Pharmaceutical Co., Ltd. romanized; Jumpcan Pharmaceutical Co., Ltd. | CDE ↗ |
| 复方聚乙二醇电解质散(III) · No verified English name | CYHS2303243 | Generic | 2023/11/24 | Chongqing Yao Gu Pharmaceutical Co., Ltd. romanized; Jumpcan Pharmaceutical Co., Ltd. | CDE ↗ |
| Magnesium Sulfate Injection | CYHS2301445 | Generic | 2023/05/30 | Chongqing Yao Gu Pharmaceutical Co., Ltd. romanized; Jumpcan Pharmaceutical Co., Ltd. | CDE ↗ |
| Potassium Chloride Granules | CYHS2300965 | Generic | 2023/04/05 | Chongqing Yao Gu Pharmaceutical Co., Ltd. romanized; Jumpcan Pharmaceutical Co., Ltd. | CDE ↗ |
| Potassium Chloride Granules | CYHS2300964 | Generic | 2023/04/05 | Chongqing Yao Gu Pharmaceutical Co., Ltd. romanized; Jumpcan Pharmaceutical Co., Ltd. | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/18 · Current coverage may be incomplete
- Chemical-drug catalogue
- Last successful update: 2026/11/18
- API registrations
- Last successful update: 2026/11/18
- NMPA drug delivery notices
- Last successful update: 2026/11/19
Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.